|
Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy Clinical research trials and Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy. Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy  Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy
Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy
For Condition: Cerebrovascular Accident,Paralysis
Status: Recruiting
Sponsor(s): National Institute of Neurological Disorders and Stroke (NINDS) ,
Synopsis: The purpose of this study is to determine if giving amphetamines along with standard rehabilitation speeds motor recovery after a stroke. In addition, if motor recovery is improved, the study will also identify the areas of the brain involved with the recovery. Researchers will use motor function ratings, PET scans, functional MRI (fMRI), electroencephalographs, and transcranial magnetic stimulation (TMS) to evaluate patients. Patients participating in the study will be placed in one of two groups; 1. Patients receiving dextroamphetamine and routine Rehabilitation Medicine 2. Patients receiving a placebo "sugar pill" and routine Rehabilitation Medicine Patients that have improved motor recovery will undergo neuroimaging and neurophysiological studies to identify areas of the brain involved.
Details: The purpose of this study is to determine if administration of dextroamphetamine (amph) linked with customarily used Rehabilitation Medicine accelerates motor recovery after stroke. Additionally, if motor recovery occurs, this study will allow identification of the brain regions activated in association with this recovery. Techniques used will include longitudinal rating of motor function, neuro-imaging with positron emission tomography (PET) and functional magnetic resonance tomography (fMRI), electroencephalography (EEG) and transcranial magnetic stimulation (TMS). Patients will be assigned to one of the two groups: amph linked with PT, and placebo linked with PT. Every patient will receive the standard of care PT. Motor recovery will be evaluated in the two groups. If motor recovery is accelerated in any of the groups, then neuroimaging and neurophysiological data will allow identification of areas and networks in the brain associated with this recovery. This is a Phase II study with potential major impact on how stroke patients are treated.
Eligibility:
Study Type: Interventional, Treatment, Safety/Efficacy
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Hemiparetic patients (right or left) (defined as a score of 55 or lower on Fugl-Meyer Scale) who had a single thromboembolic non-hemorrhagic infarction (documented by CT or MRI) 5 to 30 days before. Patients will be recruited from referrals from the community particularly from Suburban Hospital. EXCLUSION CRITERIA: Large hemorrhagic or brain stem stroke. Multiple cerebral lesions with residual deficits. Less than 5 days after stroke or greater than 30 days after stroke. Age younger than 18 or older than 80 years. History of head injury with loss of consciousness. Terminal illness such as AIDS or cancer. Severe neurological diseases other than stroke. History of severe alcohol or drug abuse. History of psychiatric illness. Unstable cardiac dysrhythmia or unresponsive arterial hypertension (greater than 160/100 mmHg). Untreated hyperthyroidism. Receiving alpha-adrenergic antagonists or agonists. Receiving major/minor tranquilizers, clonidine, prazosin, phenytoin, GABA, benzodiazepines, scopolamine, haloperidol, other neuroleptics, barbituates. Degree of aphasia or cognitive deficit that makes patients unable to give informed consent. Pregnancy. A pregnancy test will be done on admission.
Total Enrollment: 34
Location and Contact Information:
National Institute of Neurological Disorders and Stroke (NINDS) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 980115; 98-N-0115
Study Start Date: April 28, 1998
Record last reviewed: May 28, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001783
Other Paralysis Studies:
1. Assessment of Attentional Functioning in Children with HIV-1 Infection
2. Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy
3. The Early Reversibility of Rocuronium After Different Doses of Neostigmine
Related Studies:
Other Paralysis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Motor Recovery in Recent Stroke Patients Treated with Amphetamine and Physical Therapy
|
|
|
|
|
|
|
|
